Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-24-004869

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 10, 2024 56.55M sh
Stock Issued Q2 2024 · Jun 30, 2024 2.16M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $5.73M
Current Liabilities Q2 2024 · Dec 31, 2023 $4.81M
Total Liabilities Q2 2024 · Jun 30, 2024 $5.92M
Total Liabilities Q2 2024 · Dec 31, 2023 $5.48M
Current Assets Q2 2024 · Jun 30, 2024 $1.02M
Current Assets Q2 2024 · Dec 31, 2023 $1.39M
Total Assets Q2 2024 · Jun 30, 2024 $1.25M
Total Assets Q2 2024 · Dec 31, 2023 $1.67M
Shares Diluted Q2 2024 · Jun 30, 2023 50.97M sh
Shares Diluted Q2 2024 · Jun 30, 2023 50.14M sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$937K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$3.32M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$2.86M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$2.88M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.03
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.05
Eps Basic Q2 2024 · Jun 30, 2023 −$0.03
Eps Basic Q2 2024 · Jun 30, 2023 −$0.05
Sga Expense Q2 2024 · Jun 30, 2023 $1.39M
Sga Expense Q2 2024 · Jun 30, 2023 $2.17M
Rd Expense Q2 2024 · Jun 30, 2023 $66K
Rd Expense Q2 2024 · Jun 30, 2023 $73K
Net Income Q2 2024 · Jun 30, 2023 −$1.56M
Net Income Q2 2024 · Jun 30, 2023 −$2.43M
Operating Income Q2 2024 · Jun 30, 2023 −$1.51M
Operating Income Q2 2024 · Jun 30, 2023 −$2.35M
Gross Profit Q2 2024 · Jun 30, 2023 $11K
Gross Profit Q2 2024 · Jun 30, 2023 $24K
Revenue Q2 2024 · Jun 30, 2023 $44K
Revenue Q2 2024 · Jun 30, 2023 $66K